Antiviral innate immunity is initiated in response to RNA molecules that are produced in virus-infected cells 1 . These RNAs activate signalling cascades that activate the genes that encode a-and b-interferon (IFN). Signalling occurs through the interaction of the RNAs with either of two pathogen recognition receptors, retinoic acid-inducible gene-I (RIG-I, also known as DDX58) and melanoma differentiation associated gene-5 (MDA5, also known as IFIH1), which contain amino-terminal caspase activation and recruitment domains (CARD) and carboxy-terminal DExD/H Box RNA helicase motifs [2] [3] [4] [5] . RIG-I and MDA5 interact with another CARD protein, interferon-b promotor stimulator protein-1 (IPS-1, also known as MAVS, VISA and Cardif), in the mitochondrial membrane, which relays the signal through the transcription factors interferon regulatory factor 3 (IRF-3) and nuclear factor (NF)-kB to the IFN-b gene [6] [7] [8] [9] [10] . Although the signalling pathway is well understood, the origin of the RNA molecules that initiate these processes is not. Here we show that activation of the antiviral endoribonuclease, RNase L 11 , by 29,59-linked oligoadenylate (2-5A) 12 produces small RNA cleavage products from self-RNA that initiate IFN production. Accordingly, mouse embryonic fibroblasts lacking RNase L were resistant to the induction of IFN-b expression in response to 2-5A, dsRNA or viral infection. Singlestranded regions of RNA are cleaved 39 of UpUp and UpAp sequences by RNase L during viral infections, resulting in small, often duplex, RNAs 13,14 . We show that small self-RNAs produced by the action of RNase L on cellular RNA induce IFN-b expression and that the signalling involves RIG-I, MDA5 and IPS-1. Mice lacking RNase L produce significantly less IFN-b during viral infections than infected wild-type mice. Furthermore, activation of RNase L with 2-5A in vivo induced the expression of IFN-b in wild-type but not RNase L-deficient mice. Our results indicate that RNase L has an essential role in the innate antiviral immune response that relieves the requirement for direct sensing of non-self RNA.
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To determine the effect of RNase L on the induction of IFN-b, we transfected wild-type and Rnasel -/-(RNase L-deficient) 15 mouse embryonic fibroblasts (MEFs) with either dephosphorylated (inactive) or triphosphorylated (active) trimer 2-5A 16 . Transfection of dephosphorylated 2-5A ((29-59)A 3 ) did not induce the expression of IFNb, as determined by a specific enzyme-linked immunosorbent assay (ELISA; Fig. 1a ). However, triphosphorylated 2-5A ((29-59)p 3 A 3 ), the naturally occurring activator of RNase L, potently induced IFN-b production in a dose-dependent manner in wild-type but not in RNase L-deficient cells. The RNase L-deficient cells were also relatively resistant to the induction of IFN-b expression in response to the synthetic dsRNA poly(I):poly(C) in comparison to the wild-type cells (Fig. 1b) . In addition, RNase L-deficient cells were partially resistant to the induction of IFN-b expression by the paramyxovirus, Sendai virus (SeV), a negative RNA strand virus (infection of wild-type cells produced 7.5-fold more IFN-b than did infection of RNase L-deficient cells; Fig. 1c ). Ectopic expression of RNase L in RNase L-deficient MEFs restored the induction of IFN-b expression by SeV, poly(I):poly(C) or 2-5A ( Supplementary Fig. 1 ). Showing that the nuclease function of RNase L is essential for signalling, the nucleasedead mutants of RNase L (R667A or H672A) failed to restore the induction of IFN-b expression by 2-5A ( Supplementary Fig. 1c, d ). To test our hypothesis that RNA cleavage products generated by RNase L were responsible for the induction of IFN-b expression, we performed experiments with primary MEFs lacking the RNA helicases RIG-I or MDA5, or their adaptor, IPS-1. The induction of IFN-b in response to treatment with 2-5A was greatly reduced (by .14-fold) in Rig-i -/-(RIG-I-deficient) 3 MEFs as compared to wild-type MEFs (Fig. 1d ). In addition, Mda5 -/-(MDA5-deficient) MEFs 4 were about fourfold less responsive to the induction of IFN-b by 2-5A than were wild-type MEFs (Fig. 1e) . Both RIG-I and MDA5 relay signals through IPS-1 [6] [7] [8] [9] . As a result, Ips1 -/-(IPS-1-deficient) MEFs 17 were unresponsive to the induction of IFN-b by 2-5A (Fig. 1f) .
To extend these findings to human cells, we used small inhibitory (si)RNA oligonucleotides to suppress individually the levels of RIG-I, MDA5 and IPS-1 in the human prostate cancer cell line DU145 (Fig. 2a ). A decrease in the level of each of these signalling proteins inhibited the induction of a human IFN-b promoter by 2-5A (by more than sevenfold compared to the untreated control; Fig. 2b ). By contrast, non-specific short interfering (si)RNA failed to inhibit the induction of the IFN-b promoter by 2-5A. Simultaneous knock-down of RIG-I and MDA5 nearly prevented the induction of the IFN-b promoter by 2-5A. By contrast, a reduction in the level of the RNA helicase laboratory of genetics and physiology 2 (LGP2) 18 slightly increased signalling to the IFN-b promoter by 2-5A ( Supplementary Fig. 2 ). In addition, 2-5A-induction of the IFN-b promoter in the human hepatoma cell line Huh7.5, which has a mutation in RIG-I (T55I) 19 , was 28% that of 2-5A-induced Huh7 cells, which contain wild-type RIG-I (Fig. 2c) . The impact of the RIG-I mutation on autocrine IFN signalling was apparent from the lower levels of phosphorylation of signal transducer and activator of transcription-1 (STAT-1) after 2-5A treatment in the Huh7.5 cells compared with identically treated Huh7 cells (Fig. 2d, compare lanes 3 and 6) .
To provide direct evidence that RNA cleavage products generated by RNase L are responsible for signalling, we isolated total cellular RNA from RNase L-deficient MEFs and incubated it with recombinant, purified RNase L in the presence and absence of 2-5A. The reactions were allowed to proceed until no further RNA cleavage could be detected, as monitored by fluorescence resonance energy transfer (FRET) assays using an internal RNA FRET probe 20 and by RNA size analysis using RNA chips ( Fig. 3a and Supplementary Fig.  3 ). The production of IFN-b by MEFs increased (to sixfold higher levels) after they were transfected with RNA pre-incubated with RNase L plus 2-5A, as compared to the production of IFN-b after transfection with RNA incubated in the absence of RNase L and 2-5A (Fig. 3b) . Incubation of RNA with RNase L without 2-5A provided a much smaller (twofold) increase in IFN-b induction when the RNA was subsequently transfected into MEFs, probably owing to a low level of RNA cleavage under these conditions (Supplementary Fig. 3 ). The RNA cleavage products that were ,200 nucleotides long were isolated by a solid-phase fractionation method (Fig. 3a, lanes 5-7; see Methods). Using equivalent amounts of total RNA as substrate, IFNb was induced to .10-fold higher levels in response to transfection of MEFs with small RNAs produced by incubation with RNase L plus 2-5A compared to transfection with small RNAs isolated from an LETTERS equivalent amount of total RNA incubated with or without RNase L alone (Fig. 3c) . Small RNA at #50 ng ml -1 produced by incubation with 2-5A-activated RNase L induced IFN-b and its promoter in MEFs and in human HT1080 cells, respectively ( Supplementary  Fig. 4 ). By contrast, up to 1 mg ml -1 of the small RNA fraction obtained in the absence of RNase L digestion had little or no effect.
It has been reported that the presence of free 59 triphosphorylated or duplex structures in RNA serve to discriminate self (cellular) from non-self (viral) RNA substrates and is used by RIG-I to recognise viral RNA and to initiate innate immune signalling 21, 22 . However, the small RNAs produced by RNase L contain 39-, and not 59-, monophosphoryl groups 13 . To determine how the 39-phosphoryls might contribute to the induction of IFN expression, we treated the small RNA cleavage products with calf intestinal phosphatase (CIP) under conditions that completely dephosphorylated an internal control radiolabelled RNA substrate (data not shown). Dephosphorylation with CIP reduced the production of IFN-b by 50% (Fig. 3c) . These results indicate that RIG-I and/or MDA5 are stimulated by 39-phosphorylated RNAs. However, the small RNAs that lacked terminal phosphates were still capable of signalling, albeit at a reduced level, perhaps owing to duplex structures.
RIG-I forms multimeric complexes and IRF-3 dimerizes during signalling initiated by SeV infections, as determined by native polyacrylamide gel electrophoresis (PAGE) and immunoblotting 23 (see also Fig. 3d, lane 5) . Similarly, RIG-I formed multimers and IRF-3 dimerized in response to the small RNAs (produced by RNase L plus 2-5A) in RNase L-deficient MEFs and HT1080 cells, respectively (Fig. 3d, lanes 2) . However, RNAs less than 200 nucleotides long that were isolated after incubation of total RNA with RNase L in the absence of 2-5A or without RNase L failed to induce either RIG-I multimers or IRF-3 dimers (Fig. 3d, lanes 3 and 4) . Furthermore, IFN-b was potently induced in wild-type MEFs in response to treatment with the small RNAs (Fig. 3e-g ). By contrast, IFN-b production by RIG-I-deficient and MDA5-deficient cells transfected with the small RNAs was 17.5% and 40% of the levels obtained in identically treated wild-type cells, whereas there was no detectable IFN-b produced in IPS-1-deficient cells that had been treated with the small RNAs. These results indicate that the small RNAs signal through RIG-I and MDA5 to IPS-1, thereby activating IRF-3.
To establish how RNase L contributes to IFN-b production in vivo, we infected wild-type and RNase L-deficient mice with the picornavirus, encephalomyocarditis virus (EMCV), a positive RNA strand virus or SeV. Infection of wild-type mice with EMCV produced, on average, 2.2-and 3.5-fold greater levels of IFN-b when measured 6 and 24 h after infection, respectively, when compared with similarly infected RNase L-deficient mice (Fig. 4a) . The effect of RNase L was even more pronounced after SeV infection: wild-type mice produced, on average, sixfold greater levels of IFN-b when measured 6 h after infection than did RNase L-deficient mice (Fig. 4b) . The increased IFN production in the wild-type mice, compared with the RNase L-deficient mice, was highly significant with both types of virus.
To establish that self-RNA cleavage products could signal to the IFN-b gene in vivo, we injected 2-5A into uninfected mice by the intraperitoneal route. Mock-treated wild-type and RNase L-deficient mice showed no induction of IFN-b. There was also no induction of IFN-b by 2-5A in the RNase L-deficient mice. In contrast, 2-5A induced circulating IFN-b in all wild-type mice (n 5 6; Fig. 4c ).
These findings show that RNase L is crucial for enhancing IFN-b production through the RIG-I-MDA5-IPS-1 cascade. Previously, we showed that activation of RNase L by 2-5A induced the expression of twice as many messenger RNA species, including mRNAs for many IFN-b-stimulated genes, as it suppressed 24 . The current study provides evidence that transcriptional signalling is initiated by RNase L-generated RNA cleavage products of cellular (self)-RNA (Fig. 4d) . Viruses produce 'non-self' RNAs consisting of double-stranded (ds)RNA and 59-phosphorylated RNAs that signal through RIG-I and/or MDA5 to IFN-b genes [21] [22] [23] . In addition, viral dsRNA directly activates 29-59-oligoadenylate synthetase (OAS), resulting in the production of 2-5A from ATP 12 . 2-5A stimulates RNase L and leads to the production of small RNA cleavage products that terminate in 39-phosphoryls from cellular self-RNA, as well as from some viral RNAs 14 . The products of RNase L cleavage of cellular and viral RNAs probably perform similar functions. Because RNase L cleaves exclusively single-stranded regions in RNA, the cleavage products are often duplex structures. These RNAs activate signalling by RIG-I and MDA5 to IRF-3 through the IPS-1 adaptor protein and its signalling partners, which results in the production of IFN. OAS, RIG-I and MDA5 are all induced by IFN-b at a transcriptional level, thereby further amplifying the production of IFN-b ( Fig. 4d; IFN support a broader antiviral state in the organism. Furthermore, RNase L circumvents the need for non-self viral RNAs in perpetuating and amplifying innate immunity, as by cleaving cellular RNA it produces RNA activators of RIG-I and MDA5. Because many pathogenic viruses have mechanisms to block RIG-I signalling 9, 10 or OAS function 30 during infection, strategies to regulate RNase L activation could have direct immunoenhancing and antiviral therapeutic applications.
METHODS SUMMARY
We cleaved total RNA from RNase L-deficient MEFs with RNase L activated by unfractionated 2-5A in the presence of a FRET RNA probe 20 . Control reactions lacked RNase L and/or 2-5A. Small (,200 nucleotide) RNAs were isolated using the mirVana miRNA Isolation Kit (Ambion). Small RNAs were incubated without or with CIP (NEB). Transfections of 2-5A, RNA or plasmids were performed with lipofectamine 2000 (Invitrogen) whereas poly(I):poly(C) was transfected with Fugene 6 (Roche Applied Science). We transfected siRNA oligonucleotides (5 nM) targeting human RIG-I, MDA5, IPS1, LGP2 or non-specific oligonucleotides (Dharmacon) into DU145 cells with DharmaFECT 1. Cells were transfected after 48 h with luciferase-reporter plasmids and after another 24 h with 2-5A. Luciferase activity was measured 18 h later. Alternately, 24 h after transfecting with the luciferase plasmids, cells were transfected with 2-5A or RNA for 18 h. SeV in serum-free media was added to cells in six-well plates. After 1 h, the medium was replaced with growth medium for an additional 18 h. Wild-type and Rnasel -/-mice (n 5 15 each, 5-6 weeks old) on a C57BL/6 background were inoculated intraperitoneally with 1 3 10 3 plaque forming units (pfu) of EMCV or intranasally with 320 hemagglutination units (HAU) of SeV. Sera were collected (at the times indicated) after injection and IFN-b levels were determined by ELISA (PBL Biomedical Labs). Control mice received only PBS. Treatment with 2-5A involved intraperitoneal injections of 2-5A and fugene 6 for 5 h. Mock treatments were done with fugene 6 alone.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
